133 related articles for article (PubMed ID: 2447632)
1. Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements.
Oberg K; Theodorsson-Norheim E; Norheim I
Scand J Gastroenterol; 1987 Nov; 22(9):1041-8. PubMed ID: 2447632
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
3. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
4. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
5. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.
Norheim I; Oberg K; Theodorsson-Norheim E; Lindgren PG; Lundqvist G; Magnusson A; Wide L; Wilander E
Ann Surg; 1987 Aug; 206(2):115-25. PubMed ID: 2440390
[TBL] [Abstract][Full Text] [Related]
6. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.
Feldman JM; O'Dorisio TM
Am J Med; 1986 Dec; 81(6B):41-8. PubMed ID: 2432780
[TBL] [Abstract][Full Text] [Related]
7. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome.
Sjölund K; Ekman R; Lindgren S; Rehfeld JF
Scand J Gastroenterol; 1996 Nov; 31(11):1110-4. PubMed ID: 8938905
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
9. Interdigestive fluctuations of plasma bile acid concentration: relation to interdigestive motility pattern.
Romanski KW; Peeters TL; Bormans V; Vantrappen GR; Janssens J
Hepatogastroenterology; 1987 Feb; 34(1):24-7. PubMed ID: 3570139
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and prolactin secretion in the carcinoid syndrome.
Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S
Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543
[TBL] [Abstract][Full Text] [Related]
11. Interdigestive motilin secretion and gallstone disease.
Klapdor R; Hammer E
Klin Wochenschr; 1983 Mar; 61(5):251-3. PubMed ID: 6843051
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
13. Relationship between porcine motilin-induced migrating motor complex-like activity, vagal integrity, and endogenous motilin release in dogs.
Hall KE; Greenberg GR; El-Sharkawy TY; Diamant NE
Gastroenterology; 1984 Jul; 87(1):76-85. PubMed ID: 6724277
[TBL] [Abstract][Full Text] [Related]
14. Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine.
Plank J; Feldman JM
Metabolism; 1975 Sep; 24(9):1035-46. PubMed ID: 1171350
[TBL] [Abstract][Full Text] [Related]
15. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.
Wängberg B; Nilsson O; Theodorsson E; Dahlström A; Ahlman H
Br J Cancer; 1991 Jul; 64(1):23-8. PubMed ID: 1713051
[TBL] [Abstract][Full Text] [Related]
16. Motilin in chronic idiopathic constipation.
Sjölund K; Ekman R; Akre F; Lindner P
Scand J Gastroenterol; 1986 Oct; 21(8):914-8. PubMed ID: 3775256
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
Lundin L; Norheim I; Landelius J; Oberg K; Theodorsson-Norheim E
Circulation; 1988 Feb; 77(2):264-9. PubMed ID: 2448062
[TBL] [Abstract][Full Text] [Related]
18. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
19. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.
von der Ohe MR; Camilleri M; Kvols LK; Thomforde GM
N Engl J Med; 1993 Oct; 329(15):1073-8. PubMed ID: 8371728
[TBL] [Abstract][Full Text] [Related]
20. Vagal control of migrating motor complex-related peaks in canine plasma motilin, pancreatic polypeptide, and gastrin.
Hall KE; Greenberg GR; El-Sharkawy TY; Diamant NE
Can J Physiol Pharmacol; 1983 Nov; 61(11):1289-98. PubMed ID: 6661684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
